The Money of Invention: Experimenting with the Biotech Risk Capital Model
Thursday, May 3, 2012 from 5:30 PM to 9:00 PM (EDT)
The Bioscience Network Presents:
The Money of Invention
Experimenting with the Biotech Risk Capital Model
Date & Location
Thursday, May 3, 2012
5:30 to 9:00pm
415 Main St.
Cambridge, MA 02142
The Biotech and Pharma industry is rapidly changing in an effort to meet the current demands from the market, regulators, investors and economic pressures. Please join us for an interactive discussion as we draw on our panel’s experience and look at case studies of successes and failures in biopharma investments and identify the challenges, priorities and the role of strategic partners and much more.
5:30-6:30pm: Cocktails, Hors d'oeuvres and Networking
6:30-8:00pm: The Money of Invention Panel
Bruce Booth, Partner, Life Sciences Group, Atlas Venture
Daphne Zohar, Founder, Managing Partner, PureTech Ventures
Jason Rhodes, Excutive Vice President and Chief Business Officer, Epizyme, Inc.
Steven Tregay, Founder, President and Chief Executive Officer, FORMA Therapeutics
Barrett Bready, President and Chief Executive Officer, Nabsys Inc
The Bioscience Network (TBN)
TBN is a non-profit organization providing networking and professional growth to individuals in the Bioscience industries.
Event Sponsored by:
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The Richmond Group